These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15710078)

  • 1. [Antibiotic resistance to Streptococcus pyogenes: what's happening?].
    Colomina Rodríguez J; Villar Serrano J; Burgos Teruel A; Guerrero Espejo A
    Rev Clin Esp; 2004 Dec; 204(12):661. PubMed ID: 15710078
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between differences in 16-, 14-, and 15-membered ring macrolides and Streptococcus pyogenes resistance.
    Braga PC
    Eur J Clin Microbiol Infect Dis; 2002 Feb; 21(2):146-8. PubMed ID: 11939399
    [No Abstract]   [Full Text] [Related]  

  • 3. [Susceptibility of Streptococcus pyogenes to penicillin, macrolides and clindamycin in Cádiz].
    Marín P; Márquez A; García-Martos P; García-Tapia A; Tapia J
    Rev Esp Quimioter; 2000 Sep; 13(3):318-9. PubMed ID: 11086284
    [No Abstract]   [Full Text] [Related]  

  • 4. [Resistance to erythromycin in strains of Streptococcus pyogenes isolated in the province of Barcelona].
    Viñado B; Domínguez J; Rodrigo C; Matas L
    Med Clin (Barc); 1999 Apr; 112(14):556. PubMed ID: 10363246
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrolide resistance in group A Streptococcus.
    Freeman AF; Shulman ST
    Pediatr Infect Dis J; 2002 Dec; 21(12):1158-60. PubMed ID: 12488669
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissemination of emm28 erythromycin-, clindamycin- and bacitracin-resistant Streptococcus pyogenes in Spain.
    Perez-Trallero E; Garcia C; Orden B; Marimon JM; Montes M
    Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):123-6. PubMed ID: 14712367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group A streptococcal pharyngitis and penicillin G.
    Stollerman GH
    Clin Infect Dis; 2007 Mar; 44(5):763; author reply 763-4. PubMed ID: 17278078
    [No Abstract]   [Full Text] [Related]  

  • 8. Macrolide resistance in streptococcal pharyngitis.
    Lavergne V; Thibault L; Garceau R
    CMAJ; 2007 Jul; 177(2):177. PubMed ID: 17638961
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003.
    Malhotra-Kumar S; Lammens C; Chapelle S; Wijdooghe M; Piessens J; Van Herck K; Goossens H
    Emerg Infect Dis; 2005 Jun; 11(6):939-42. PubMed ID: 15963292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance rates and phenotypic characterization of Streptococcus pyogenes in a paediatric population in Northern Spain (2005-2015)].
    Calle-Miguel L; Pérez-Méndez C; Miguel-Martínez MD; Lombraña-Álvarez E; García-García E; Solís-Sánchez G
    Rev Esp Quimioter; 2017 Apr; 30(2):90-95. PubMed ID: 28233483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.
    Zafar A; Hasan R; Nizamuddin S; Mahmood N; Mukhtar S; Ali F; Morrissey I; Barker K; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i103-9. PubMed ID: 27048578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
    Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance to macrolides in Streptococcus pyogenes].
    Bellido JL; García-Sáenz JA; Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
    Rev Esp Quimioter; 1998 Sep; 11(3):196-204. PubMed ID: 9795305
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythromycin resistance in Streptococcus pyogenes in Italy.
    Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
    Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain).
    Oliver MA; García-Delafuente C; Cano ME; Pérez-Hernández F; Martínez-Martínez L; Albertí S
    J Antimicrob Chemother; 2007 Aug; 60(2):450-2. PubMed ID: 17540676
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from adult patients with respiratory tract and skin and soft tissue infections in four southern European countries.
    Soriano F; Granizo JJ; Fernández-Roblas R; Esteban J; Gadea I; Gracia M; Coronel P; Gimeno M; Ródenas E
    J Chemother; 2003 Jun; 15(3):293-5. PubMed ID: 12868559
    [No Abstract]   [Full Text] [Related]  

  • 17. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.
    Alós JI; Aracil B; Oteo J; Gómez-Garcés JL;
    J Antimicrob Chemother; 2003 Feb; 51(2):333-7. PubMed ID: 12562699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
    Bingen E; Bidet P; Mihaila-Amrouche L; Doit C; Forcet S; Brahimi N; Bouvet A; Cohen R
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3559-62. PubMed ID: 15328126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance trends in Streptococcus pyogenes (PROTEKT years 1-3 [1999-2002]).
    Cohen R; Green M
    J Chemother; 2004 Dec; 16 Suppl 6():71-82. PubMed ID: 15690687
    [No Abstract]   [Full Text] [Related]  

  • 20. Trends in Streptococcus pyogenes resistance to erythromycin in Slovakia: is there a correlation with consumption?
    Krcmery V; Foltan V; Langsadl L; Liskov A; Babela R
    Scand J Infect Dis; 2002; 34(5):400. PubMed ID: 12069033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.